Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023

VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. “It is an incredible honor to be recognized as one of the Fierce 15 biotech companies for 2023,” said Bernd Boidol, Ph.D., chief executive offi

Fierce Biotech's 2022 Fierce 15

Chris Jenkins على LinkedIn: #genetherapy #community

見時知幾：2023 年Fierce15 藥企預示着哪些投資趨勢- LongPort

News - Proxygen

Mitchell Pease on LinkedIn: #innovation #biotech #lifesciences

Jacob Perrett on LinkedIn: What does July's biotech funding reveal

Mitchell Pease on LinkedIn: #innovation #biotech #lifesciences

Chris Jenkins on LinkedIn: Gene Therapy Finds New Life in an Old Home

Chris Jenkins on LinkedIn: Introducing Fierce Biotech's 2023 Fierce 15

Fierce Biotech on LinkedIn: Researchers predict Alzheimer's

Jacob Perrett on LinkedIn: What does July's biotech funding reveal

Fierce Life Sciences Events on LinkedIn: The Future of Biotech

Mark Federici on LinkedIn: Fierce Biotech Names Proxygen a “Fierce

Jacob Perrett on LinkedIn: VC funding update: Which Boston-area